Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,239
Closed -$503K 27
2022
Q3
$503K Buy
6,239
+1,200
+24% +$114K 0.5% 66
2022
Q2
$445K Buy
5,039
+300
+6% +$31.4K 0.4% 83
2022
Q1
$630K Buy
4,739
+400
+9% +$50.4K 0.43% 82
2021
Q4
$729K Buy
4,339
+100
+2% +$15.5K 0.48% 75
2021
Q3
$576K Sell
4,239
-2,961
-41% -$382K 0.37% 100
2021
Q2
$816K Buy
7,200
+1,100
+18% +$106K 0.52% 71
2021
Q1
$517K Buy
6,100
+2,500
+69% +$209K 0.35% 94
2020
Q4
$276K Buy
+3,600
New +$243K 0.18% 134

Other funds holding DAVA

Apogem Capital's DAVA Position: Q4 2022 in Review

Apogem Capital sold out of Endava (DAVA) in Q4 2022, closing a stake of 6,239 shares — an estimated $503K sold.

Apogem Capital first reported a position in DAVA in Q4 2020 and held it in 8 quarters. The position peaked at $816K in Q2 2021. 188 funds tracked by Wall St. Rank hold DAVA as of Q4 2022.

  • Apogem Capital reported no remaining Endava position as of Q4 2022 after selling out during the quarter.
  • Apogem Capital sold 6,239 Endava shares in Q4 2022, an estimated $503K.
  • Apogem Capital first reported a position in Endava in Q4 2020 and held it in 8 quarters.
  • Apogem Capital's Endava position peaked at $816K in Q2 2021.
  • 188 funds tracked by Wall St. Rank held Endava as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.